Please wait while we load the requested 6-K report or click the link below:
https://last10k.com/sec-filings/report/1129928/000114420418055216/tv505398_6k.htm
December 2022
December 2022
November 2022
November 2022
November 2022
November 2022
November 2022
October 2022
October 2022
September 2022
Please wait while we load the requested 6-K report or click the link below:
https://last10k.com/sec-filings/report/1129928/000114420418055216/tv505398_6k.htm
Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Oncolytics Biotech Inc.
Oncolytics Biotech Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
Oncolytics Biotech Inc provided additional information to their SEC Filing as exhibits
Ticker: ONCY
CIK: 1129928
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001144204-18-055216
Submitted to the SEC: Wed Oct 24 2018 9:11:00 PM EST
Accepted by the SEC: Thu Oct 25 2018
Period: Wednesday, October 24, 2018
Industry: Pharmaceutical Preparations